Lebwohl, Mark, Richard B. Warren, Shinichi Imafuku, Jerry Bagel, April W. Armstrong, Thierry Passeron, Subhashis Banerjee, Matthew J. Colombo, Thomas Scharnitz, Kim Hoyt, Diamant Thaci, and Andrew Blauvelt. “Deucravacitinib Long-Term Efficacy Through 4 Years in Week 16 Placebo Crossover Patients in the Phase 3 POETYK PSO-1, PSO-2, and LTE Program”. SKIN The Journal of Cutaneous Medicine 8, no. 4 (July 23, 2024): s408. Accessed July 23, 2024. https://jofskin.org/index.php/skin/article/view/2872.